The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients

PURPOSE: Tacrolimus (Tac) and cyclosporine (CsA) are mainly metabolized by CYP3A4 and CYP3A5. Several studies have demonstrated an association between the CYP3A5 genotype and Tac dose requirements. Recently, CYP3A4, PPARA, and POR gene variants have been shown to influence CYP3A metabolism. The pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Lunde, Ingrid, Bremer, Sara, Midtvedt, Karsten, Mohebi, Beata, Dahl, Miriam, Bergan, Stein, Åsberg, Anders, Christensen, Hege
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Pharmacogenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025175/
https://www.ncbi.nlm.nih.gov/pubmed/24658827
http://dx.doi.org/10.1007/s00228-014-1656-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025175/
https://www.ncbi.nlm.nih.gov/pubmed/24658827
http://dx.doi.org/10.1007/s00228-014-1656-3

Ejemplares similares